CNDAConfidentiality Non-Disclosure Agreement
CNDACour Nationale du Droit d'Asile (French: National Court of the Right of Asylum)
CNDACertified Network Defense Architect
CNDACherished Numbers Dealers Association (UK license plate broker/registry)
CNDACalifornia Naturopathic Doctors Association
CNDACorporate Non-Disclosure Agreement
CNDACanadian Naval Divers Association
CNDAChicago and Northern District Association of Club Women
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
For its maiden international flight, Royal Air carried 91 passengers from Macau International Airport to CNDA and another 44 passengers from CNDA to Macau.
Biopharmaceutical company CStone Pharmaceuticals (CStone) reported on Monday the receipt of approval from the China National Drug Administration (CNDA) for its IND application for the investigational cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) monoclonal antibody,CS1002.
Both CNDA and KROO are designed to provide additional Alpha exposure as satellite holdings built around an investor's core equity portfolio.
Richard Ottaway MP for Croydon South, who originally presented the Bill, said: "It's a great achievement for the CNDA to have helped get a Private Members Bill through Parliament."
que a CST nao tem nenhuma questao legal pendente nas agencias ambientais de acordo com o Certidao Negativa de Dividas Ambientais (CNDA no.
The demand, popularity and consequently the values of most registration numbers, have soared over recent years and CNDA members have sold and transferred hundreds of thousands of them for the public.
CNDA = [(log([]) - K1/log([E.sub.cross-flow]) - K1) -1] * 100 (2)
At the CNDA meeting, Kubas presented results of a wide-ranging survey that suggests publishers and advertisers have dramatically different perceptions about newspapers.
The China National Drug Administration (CNDA) has granted marketing authorisation to Switzerland-based Roche for its Alecensa (alectinib) as a monotherapy treatment for patients with anaplastic lymphoma kinase (ALK) positive and advanced non-small cell lung cancer (NSCLC), it was reported yesterday.
Shanghai-based biotech company I-Mab Biopharma reported on Tuesday the submission of an investigational new drug (IND) application to China National Drug Administration (CNDA) for TJ202/MOR202 for the treatment of multiple myeloma,the second most common blood cancer worldwide.
Bristol-Myers announced that the China National Drug Administration, or CNDA, has approved Opdivo for the treatment of locally advanced or metastatic non-small cell lung cancer, or NSCLC, after prior platinum-based chemotherapy in adult patients without EGFR or ALK genomic tumor aberrations.